首页> 外文OA文献 >Synthesis, structural characterization and cytotoxic activity of ternary copper(II)-dipeptide-phenanthroline complexes. A step towards the development of new copper compounds for the treatment of cancer
【2h】

Synthesis, structural characterization and cytotoxic activity of ternary copper(II)-dipeptide-phenanthroline complexes. A step towards the development of new copper compounds for the treatment of cancer

机译:三元铜(II) - 二肽 - 菲咯啉络合物的合成,结构表征和细胞毒活性。迈向开发用于治疗癌症的新铜化合物的一步

摘要

In the search for new compounds with antitumor activity, coordination complexes with different metals are being studied by our group. This work presents the synthesis and characterization of six copper complexes with general stoichiometry [Cu(L-dipeptide)(phen)]·nH2O (were phen= 1,10-phenanthroline) and their cytotoxic activities against tumor cell lines. To characterize these systems, analytical and spectroscopic studies were performed in solid state (by UV-visible, IR, X-ray diffraction) including the crystal structure of four new complexes (of the six complexes studied): [Cu(Ala-Phe)(phen)]·4H2O, [Cu(Phe-Ala)(phen)]·4H2O, [Cu(Phe-Val)(phen)]·4.5H2O and [Cu(Phe-Phe)(phen)]·3H2O. In all of them, the copper ion is situated in a distorted squared pyramidal environment. The phen ligand is perpendicular to the dipeptide, therefore exposed and potentially available for interaction with biological molecules. In addition, for all the studied complexes, structural information in solution using EPR and UV-visible spectroscopieswere obtained, showing that the coordination observed in solid state ismaintained. The lipophilicity, DNA binding and albumin interaction were also studied. Biological experiments showed that all the complexes induce cell death in the cell lines: HeLa (human cervical adenocarcinoma),MCF-7 (human metastatic breast adenocarcinoma) and A549 (human lung epithelial carcinoma). Among the six complexes, [Cu(Ala-Phe)(phen)] presents the lowest IC50 values. Taken together all these data we hypothesize that [Cu(Ala-Phe)(phen)] may be a good candidate for further studies in vivo.
机译:在寻找具有抗肿瘤活性的新化合物时,我们小组正在研究与不同金属的配位络合物。这项工作提出了六种具有一般化学计量比的铜配合物[Cu(L-二肽)(phen)]·nH2O(phen = 1,10-phenthroline)的合成和表征,以及它们对肿瘤细胞系的细胞毒活性。为了表征这些系统,在固态(通过UV-可见,IR,X射线衍射)中进行了分析和光谱研究,包括四个新配合物(研究的六个配合物)的晶体结构:[Cu(Ala-Phe) (phen)]·4H2O,[Cu(Phe-Ala)(phen)]·4H2O,[Cu(Phe-Val)(phen)]·4.5H2O和[Cu(Phe-Phe)(phen)]·3H2O。所有这些中,铜离子都位于扭曲的方形锥体环境中。 phen配体垂直于二肽,因此会暴露出来,并有可能与生物分子相互作用。此外,对于所有研究的配合物,使用EPR和UV-可见分光光度法在溶液中获得了结构信息,表明保持了在固态下观察到的配位。还研究了亲脂性,DNA结合和白蛋白相互作用。生物学实验表明,所有复合物均可在以下细胞系中诱导细胞死亡:HeLa(人宫颈腺癌),MCF-7(人转移性乳腺腺癌)和A549(人肺上皮癌)。在这六个配合物中,[Cu(Ala-Phe)(phen)]的IC50值最低。综合所有这些数据,我们假设[Cu(Ala-Phe)(phen)]可能是体内进一步研究的良好候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号